Table 1.
mAbs against EBOV GP, their relative signal on SP-IRIS, binding domains on the GP, and neutralization activities.
Anti-EBOV GP Ab | Signal on SP-IRIS | Binding domain | Neutralization activity |
---|---|---|---|
13F6 | + + + + | Mucin-like domain | Non-neutralizing |
13C6 | + + + | Glycan cap | Non-neutralizing |
6D8 | + + + | Mucin-like domain | Non-neutralizing |
1H3 | + + + | Glycan cap | Non-neutralizing |
4G7 | + + | GP1/GP2 (base) | Neutralizing |
2G4 | + + | GP1/GP2 (base) | Neutralizing |
KZ52 | + + | GP1/GP2 (base) | Neutralizing |
15H10 | + | GP2 (HR2/MPER) | Non-neutralizing |
3F10 | + | Unknown | Non-neutralizing* |
16F6 | − | GP1/GP2 (base) | Neutralizing* |
The degree of binding is denoted by + /- symbols: + + + + very high, + + + high, + + medium, + little, − no binding.
*Neutralization tests for 3F10 and 16F6 were performed by USAMRIID.